Clinical Trials Browser

Small Cell Lung Cancer Extensive Stage × durvalumab × 1 year × Clear all

NCT05856695 2025-09-24

TAXIO

Phase 2 Active not recruiting

Small Cell Lung Cancer Extensive Stage